SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-023857
Filing Date
2022-08-30
Accepted
2022-08-30 06:06:57
Documents
15
Period of Report
2022-08-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K sgmo-20220830.htm   iXBRL 8-K 56976
5 GRAPHIC sgmo-20220830_g1.jpg GRAPHIC 1449459
6 GRAPHIC sgmo-20220830_g2.jpg GRAPHIC 673718
7 GRAPHIC sgmo-20220830_g3.jpg GRAPHIC 78608
  Complete submission text file 0001628280-22-023857.txt   4917591

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20220830.xsd EX-101.SCH 1941
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20220830_lab.xml EX-101.LAB 24132
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20220830_pre.xml EX-101.PRE 12545
9 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20220830_htm.xml XML 11309
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 221212845
SIC: 2836 Biological Products, (No Diagnostic Substances)